Quantitative assessment of retinal changes in COVID-19 patients
- 20 May 2021
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 104 (6) , 717-722
Abstract
The SARS-COV 2 virus, which is responsible for the COVID-19 pandemic, acts on the angiotensin converting enzyme 2 (ACE-2) receptor in the host cell. Ocular effects may occur because of the ACE-2 re...Keywords
This publication has 24 references indexed in Scilit:
- Therapeutic targets of renin-angiotensin system in ocular disordersJournal of Current Ophthalmology, 2017
- Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epitheliumJournal of Neuroinflammation, 2016
- Angiotensin(1-7) and ACE2, “The Hot Spots” of Renin-Angiotensin System, Detected in the Human Aqueous HumorThe Open Ophthalmology Journal, 2015
- Molecular pathology of emerging coronavirus infectionsThe Journal of Pathology, 2014
- Activities of Angiotensin-Converting Enzymes ACE1 and ACE2 and Inhibition by Bioactive Peptides in Porcine Ocular TissuesJournal of Ocular Pharmacology and Therapeutics, 2009
- Experimental Optic Neuritis Induced by a Demyelinating Strain of Mouse Hepatitis VirusJournal of Virology, 2008
- Angiotensin II and Its Receptor Subtypes in the Human RetinaInvestigative Ophthalmology & Visual Science, 2007
- Human Coronavirus NL63, FranceEmerging Infectious Diseases, 2005
- Identification of a new human coronavirusNature Medicine, 2004
- Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy.The Journal of Immunology, 1993